PGEN vs RARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

PGEN

34.5
AI Score
VS
RARE Wins

RARE

52.5
AI Score

Investment Advisor Scores

PGEN

35score
Recommendation
SELL

RARE

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PGEN RARE Winner
Revenue 78.23M 350.00M RARE
Net Income 12.14M -277.00M PGEN
Net Margin 15.5% -79.1% PGEN
Operating Income 16.65M -244.00M PGEN
ROE 27.9% 95.2% RARE
ROA 7.1% -21.9% PGEN
Total Assets 170.30M 1.26B RARE
Cash 16.33M 125.00M RARE
Current Ratio 4.58 1.73 PGEN
Free Cash Flow -62.29M -296.00M PGEN

Relative Price Performance (Last 90 Days)

PGEN 1M: +21.8% · 3M: +52.5% RARE 1M: -42.6% · 3M: -54.8%

Current Technical Phase

PGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.8% over 20 days), RSI 67

RSI (14): 67.1 · Price: $8.54

RARE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -24.3%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $15.22

Fundamentals Snapshot

Metric PGEN RARE
Market Cap — —
Forward P/E 13.5 22.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 63.2% 0.3%
Gross Margin 0.5% -0.2%
Operating Margin 0.4% -0.4%
EPS -1.02 -5.72
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RARE is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.